AstraZeneca's Covid-19 vaccine 70.4% effective at preventing the infection


 

Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222, peer-reviewed and published in The Lancet on Wednesday demonstrated that the vaccine is safe and effective at preventing symptomatic COVID-19 and that it protects against severe disease and hospitalisation.

The interim analysis for efficacy was based on 11,636 participants accruing 131 symptomatic infections from the Phase III UK and Brazil trials conducted by Oxford University.

As announced on November 23, the primary efficacy endpoint of the programme statistical plan, based on the pooling of two dosing regimens, showed that the vaccine is 70.4 per cent effective at preventing symptomatic COVID-19 occurring more than 14 days after receiving two doses of the vaccine. A secondary efficacy endpoint of prevention of severe disease demonstrated no cases of severe infections or hospitalisations in the vaccine group. Read More

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Budgeting Myths Busted: 7 Common Misconceptions Revealed

Image
  Creating a budget is one of the best habits that can assist you in managing your finances more effectively. A budget can help you see where your money is going and what you need to do to control your expenses and increase your savings. Moreover, sometimes what not to do is just as important as how to manage your finances. Let’s delve into what a budget is, why it is necessary, and how to create one. Not only that, but we will also discuss 7 common myths about budgets that are prevalent among people. What is a Budget? Money holds significant importance in life, but managing it properly is equally crucial. Sometimes, expenses seem to escalate to the point where it becomes unclear where the money is going. That’s where budgeting comes in! In simple terms, a budget is an estimate of your future income and expenses. You can create it for a month, a year, or for a specific goal. Governments create budgets, companies create budgets, and you can create your own budget, regardles...
Read more

India to test 100-yr-old vaccine on adults as war on Covid-19 hots up

Image
Serum Institute’s recombinant BCG vaccine would be the first vaccine candidate in India to start human trials within the next two weeks. This is to test if the vaccine, administered at birth to Indians to fight tuberculosis, can also boost immunity in adults against the novel coronavirus. If all goes well, the vaccine, which has a proven safety track record, can be in the market by the end of this year. Serum Institute can make 300-400 million doses of this vaccine. The Bacillus Calmette-Gurein (BCG) vaccine named after French microbiologists Albert Calmette and Camille Guérin, is given to infants in India upon birth. Globally, the practice is to administer it to children below one year of age. Read More
Read more

India Coronavirus Dispatch: Are politicians potential super-spreaders?

Image
  In Punjab, the age group 0-50 accounts for 73.7 per cent of the total state case load. The mortality rate among those infected in this age group, however, is 26.8 per cent. The age group 51-90 accounts for 26.3 per cent of infections but has a mortality rate of 72.4 per cent. Comorbidities, experts say, are the major reason driving the high fatality rate among the elderly. Till August 28, about 17 per cent of infections were noted in the age group 41-50, some 15 per cent for those aged 51-60, around eight per cent for the 61-70 group and only three per cent for 71-80. An official further noted that diabetes is emerging as major problem in Punjab because of the state’s ‘rich diet and sedentary lifestyle’. This, he says, needs to be curbed along with following precautions like wearing face masks and maintaining social distance. Karnataka has seen over 40 legislators, across party lines, test positive for Covid-19 so far. Epidemiologists have now warned that those in public life ...
Read more